Record:   Prev Next
Title Cellular and molecular mechanisms of drugs of abuse and neurotoxicity [Electronic Resource] : cocaine, GHB, and substituted amphetamines / edited by Syed F. Ali and Francesco Fornai
Imprint Boston, Mass. : Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2006
book jacket
Descript 1 online resource (xvi, 676 p.) : ill.
Series Annals of the New York Academy of Sciences, 0077-8923 ; v. 1074
Annals of the New York Academy of Sciences ; v. 1074
Note "Result of a meeting entitled Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity: Cocaine, GHB and Substituted Amphetamines, and held on August 16-19, 2005 on Isola di San Servolo, Venice, Italy"--P. [vii]
Includes bibliographical references and index
Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors -- Cellular and molecular mechanisms of drugs of abuse and neurotoxicity: cocaine, GHB, and substituted amphetamines. Proceedings of a meeting. August 16-19, 2005. Venice, Italy -- Serial analysis of gene expression in the rat striatum following methamphetamine administration -- Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage -- Gene expression in the brain from fluoxetine-injected mouse using DNA microarray -- Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats -- Effects of L-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity -- Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity -- Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis -- Repeated methamphetamine administration alters expression of the NMDA receptor channel epsilon2 subunit and kinesins in the mouse brain -- Genes and gene expression in the brains of human alcoholics -- Association study of the tumor necrosis factor-alpha gene and its 1A receptor gene with methamphetamine dependence -- Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence -- Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice -- Effects of methamphetamine on the cerebellar cortex: a preliminary study -- Age-dependent effects of methamphetamine on VMAT-2 -- Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats -- In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition -- Human immunodeficiency virus-1 protein tat and methamphetamine interactions -- Overexpression of alpha-synuclein following methamphetamine: is it good or bad? -- Alterations in blood-brain barrier function by morphine and methamphetamine -- Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse -- Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death -- Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs -- Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine -- Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine -- Estrogen, testosterone, and methamphetamine toxicity -- Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice -- Links between nutrition, drug abuse, and the metabolic syndrome -- Inclusion dynamics in PC12 is comparable between amphetamines and MPTP -- On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons -- Effect of oxidative stress induced by L-dopa on endogenous antioxidants in PC-12 cells -- Dopamine stimulation via infusion in the lateral ventricle -- Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures -- Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism -- MDMA and seizures: a dangerous liaison?
Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys -- MDMA induces caspase-3 activation in the limbic system but not in striatum -- Induction by cocaine of the serotonergic 5-HT3 receptor in rat cerebellum -- Alpha-noradrenergic receptors modulate the development and expression of cocaine sensitization -- AMPA and NMDA receptors in P2 fractions of cocaine and cocaine-prazosin-treated rats -- No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence -- Differential effects of donepezil on methamphetamine and cocaine dependencies -- Hippocampal synaptic plasticity and water maze learning in cocaine self-administered rats -- Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study -- Persistent and reversible morphine withdrawal-induced morphological changes in the nucleus accumbens -- Expression of NR1/NR2B N-methyl-D-aspartate receptors enhances heroin toxicity in HEK293 cells -- Brain blood flow SPET imaging in heroin abusers -- The comet assay as a method of assessment of neurotoxicity: usefulness for drugs of abuse -- A potent serotonin-modulating compound AP-267 attenuates morphine withdrawal-induced blood-brain barrier dysfunction in rats -- Peri-response pharmacokinetics of remifentanil during a self-administration session indicates that neither blood nor brain levels are titrated -- Nicotine alters nicotinic receptor subunit levels differently in developing Mammalian sympathetic neurons -- Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain -- Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion -- Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines -- Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics -- CNS aspects of prenatal drug exposure: drugs of abuse, toxins, and corticosteroids -- Effects of prenatal exposure to methamphetamine on the development of the rat retina -- Effects of postnatal exposure to methamphetamine on the development of the rat retina -- Prenatal exposure to cocaine and enriched environment: effects on social interactions -- Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine -- MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test -- Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study -- Mechanism-based approaches for the reversal of drug neurobehavioral teratogenicity
Also issued in print
Mode of access: World Wide Web
Subject Drugs of abuse -- Congresses
Neurotoxicology -- Congresses
Amphetamines -- Congresses
Cocaine -- Congresses
Gamma-hydroxybutyrate -- Congresses
Drogues illicites
Hydroxybutyrate de sodium
Cocaine -- metabolism
Amphetamines -- adverse effects
Amphetamines -- metabolism
Cocaine -- adverse effects
Neurotoxicity Syndromes
Street Drugs -- pharmacokinetics
Drugs. gtt
Verslaving. gtt
Moleculaire biologie. gtt
Electronic books
Rauschgift. swd
Neurotoxikologie. swd
Alt Author Ali, Syed F
Fornai, F. (Francesco)
New York Academy of Sciences
Record:   Prev Next